Hepatitis C virus RNA load in treatment is the best time to relapsed patients:: week two of predict the complete response

被引:2
作者
Halfon, P
Khiri, H
Tran, A
Pénaranda, G
Courcambeck, J
Joly, H
Ouzan, D
机构
[1] Hop Ambroise Pare, Lab Alphabio, Virol Dept, F-13006 Marseille, France
[2] Hop Archet 2, Nice, France
[3] Arnault Tzanck Inst, St Laurent Du Var, France
关键词
HCV; viral load; kinetic; therapeutic response; IFN; ribavirin;
D O I
10.1097/00042737-200310000-00001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective An early virological response has been shown to be predictive of a sustained virological response to antiviral treatment in chronic hepatitis C infection. The aim of the study was to analyse viral kinetics during the first 6 weeks of treatment (interferon plus ribavirin) in 18 relapsed hepatitis C patients after a first course of interferon monotherapy. Methods We studied 18 relapsed patients treated with interferon and ribavirin. A sustained virological response (negative HCV RNA measured by polymerase chain reaction 6 months after the end of therapy) was obtained in 12 patients. Samples were obtained before therapy and each week for 6 weeks during therapy; HCV RNA levels were determined using quantitative bDNA. Results At the end of week two, a viral-load drop of more than 2.20 log was observed in all the 12 patients with a sustained virological response and in none of the six other patients. When we considered the median of the viral load reduction from baseline for each week of treatment, week two appeared to be the time point most predictive of a sustained viral response (positive predictive value 83%; negative predictive value 92%). Conclusion During treatment with interferon plus ribavirin in relapsed hepatitis C patients, viral kinetics showed that the second week of treatment appeared to be the time point most predictive of a sustained viral response. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:1067 / 1071
页数:5
相关论文
共 29 条
[1]  
Bain VG, 2001, AM J GASTROENTEROL, V96, P2818, DOI 10.1111/j.1572-0241.2001.04234.x
[2]   Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin [J].
Bekkering, FC ;
Brouwer, JT ;
Hansen, BE ;
Schalm, SW .
JOURNAL OF HEPATOLOGY, 2001, 34 (03) :435-440
[3]   Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model [J].
Bekkering, FC ;
Stalgis, C ;
McHutchison, JG ;
Brouwer, JT ;
Perelson, AS .
HEPATOLOGY, 2001, 33 (02) :419-423
[4]  
Blendis Laurie, 2002, Gastroenterology, V122, P237, DOI 10.1016/S0016-5085(02)80088-9
[5]   Early predictors of response to treatment in patients with chronic hepatitis C [J].
Civeira, MP ;
Prieto, J .
JOURNAL OF HEPATOLOGY, 1999, 31 :237-243
[6]  
Enomoto M, 2002, AM J GASTROENTEROL, V97, P420
[7]  
Fallows G, 2000, Can J Gastroenterol, V14 Suppl B, p30B
[8]   Pegylated (40 kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin:: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study [J].
Fried, MW ;
Shiffman, ML ;
Reddy, RK ;
Smith, C ;
Marino, G ;
Goncales, F ;
Haeussinger, D ;
Diago, M ;
Carosi, G ;
Zarski, JP ;
Hoffman, J ;
Yu, J .
GASTROENTEROLOGY, 2001, 120 (05) :A55-A55
[9]   Decline of hepatitis C virus load in serum during the first 24 h after administration of in interferon-beta as a predictor of the efficacy of therapy [J].
Fukutomi, T ;
Nakamuta, M ;
Fukutomi, M ;
Iwao, M ;
Watanabe, H ;
Hiroshige, K ;
Tanabe, Y ;
Nawata, H .
JOURNAL OF HEPATOLOGY, 2001, 34 (01) :100-107
[10]   Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA [J].
Halfon, P ;
Khiri, H ;
Gerolami, V ;
Bourliere, M ;
Feryn, JM ;
Reynier, P ;
Gauthier, A ;
Cartouzou, G .
JOURNAL OF HEPATOLOGY, 1996, 25 (03) :307-311